ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Evaluation of genomic characteristics of Escherichia coli associated with bovine mastitis and the potential utility of alternative antimicrobial methods.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mastitis is a disease that affects dairy cattle and can be caused by multidrug-resistant Escherichia coli, causing losses to the agricultural sector. To address this, research into new substances with antimicrobial activity is crucial. Thus, the objective of this study was to evaluate the efficacy of extracts of Commiphora leptophloeos, Amburana cearensis, Agave sisalana, and highly soluble polypyrrole (Hs-PPy) against E. coli isolates. Eight E. coli isolates from bovine mastitis and a standard strain were used. The presence of efflux pumps was investigated by ethidium bromide extrusion. Sequencing was performed on the Illumina HiSeq 2500 platform using a 2 × 150 bp library with quality assessed via FastQC and assembly completed using Unicyler. Genome annotation and the identification of resistance and virulence genes were carried out using PROKKA and PanViTa, respectively. Species confirmation as E. coli was achieved via Jspecies and pyANI public genomes from NCBI. Finally, antimicrobial activity was determined by broth microdilution. Among the natural products tested against the isolates only A. cearensis showed antibacterial activity, with a concentration of 12,500 µg/mL, whereas Hs-PPy showed activity at 250 µg/mL. The isolates tested positive for the presence of efflux pump genes, but only 3 isolates expressed the mechanism in vitro. The natural products were not effective in eliminating the bacteria. Hs-PPy was the only compound that demonstrated bactericidal activity against the bacteria, proving to be an alternative for bactericidal action, even in the presence of genes that inhibit its action against a wide variety of compounds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.